Lung Cancer Screening

Overview

4.7 out of 5 (24 Reviews)

Credits

1.00

Post Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Worldwide lung cancer has the highest rate of mortality and is the leading cause of cancer deaths. The incidence of lung cancer is approximately equal to its mortality. There are approximately 1.8 million new cases of lung cancer every year globally and over 1.6 million deaths secondary to this. The survival rates for lung cancer are abysmal, in the United States the overall 5-year survival is as low as 18% which is in sharp contrast to the high rates of survival for breast, colon, and prostate cancer at 90, 65 and almost 100% respectively. These low rates of survival link directly with most lung cancers only getting diagnosed when the disease is in advanced stages. Before screening interventions, lung cancers in early stages were found mostly as a coincidental finding. Due to the late presentation of these patients, survival beyond a few years was not possible. Due to these problems, there was a global push for screening modalities for lung cancer to ensure the identification of malignancy occurred earlier in the disease process. The average 5-year survival in the United States of patients with lung cancer is 17.7%; however, this number drastically changes if we account for the stage of the disease at the time of diagnosis. In patients with localized disease, the survival rates are as high as 55.2%. However, only 16% of patients get diagnosed at this early stage of their disease. This difference in survival rates further highlights the absolute need for a reliable screening tool for patients at risk for lung cancer. This activity reviews the considerations for lung cancer screening and discusses the role of the interprofessional team in considering the limited screen tools available for patients at higher risk.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Describe the leading cause of cancer deaths worldwide.

  • Review the survival rates of lung cancer.

  • Outline the challenges and methods of early diagnosis of lung cancer.

  • Summarize the considerations for lung cancer screening and outline the role of the interprofessional team in considering the limited screen tools available for patients at higher risk.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Sandeep S. on 5/8/2021

Paul F. on 7/21/2021

Deborah Z. on 8/13/2021

Mike G. on 9/3/2021

Yewande A. on 10/30/2021

Susan B. on 4/9/2022

Christina M. on 8/13/2022

Elisabeth H. on 9/3/2022

Michael D. on 2/4/2023

Melanie P. on 3/20/2023

Laxmi S. on 6/8/2023

Vincent B. on 7/21/2023

Jodi H. on 9/20/2023

Preeti P. on 11/7/2023

Sharon D. on 11/16/2023

Padmini N. on 11/25/2023

Yaakov W. on 12/13/2023

Great review.

Richard P. on 12/17/2023

Arnbjorn T. on 12/19/2023

Padmini N. on 1/17/2024

Steven L. on 1/23/2024

Tyler S. on 2/1/2024

Fariborz M. on 3/7/2024

joerg r. on 3/19/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$49 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user